PHAT - Phathom Pharmaceuticals, Inc.

QQQ $ 476.48 $ 0.82 (0.17 %)

DIA $ 408.41 $ 1.67 (0.41 %)

SPY $ 556.61 $ 1.72 (0.31 %)

TLT $ 98.03 $ 0.09 (0.09 %)

GLD $ 231.36 $ 1.16 (0.5 %)

Previous Close

$ 12.45

Open

$ 13.14

Bid

$ 12.83 x 200

Ask

$ 12.89 x 200

Day's Range

$ 12.86 - $ 13.51

52 Week Range

$ 6.07 - $ 15.52

Volume

562,257

Average Volume

Market Cap

729.05M

Beta (5Y Monthly)

$ 1.05

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-08-2024	06-30-2024	10-Q
2	05-09-2024	03-31-2024	10-Q
3	03-07-2024	12-31-2023	10-K
4	11-09-2023	09-30-2023	10-Q
5	08-10-2023	06-30-2023	10-Q
6	05-10-2023	03-31-2023	10-Q
7	02-28-2023	12-31-2022	10-K
8	11-08-2022	09-30-2022	10-Q
9	08-02-2022	06-30-2022	10-Q
10	05-10-2022	03-31-2022	10-Q
11	03-01-2022	12-31-2021	10-K
12	11-08-2021	09-30-2021	10-Q
13	08-10-2021	06-30-2021	10-Q
14	05-11-2021	03-31-2021	10-Q
15	03-30-2021	12-31-2020	10-K
16	11-10-2020	09-30-2020	10-Q
17	08-06-2020	06-30-2020	10-Q
18	05-12-2020	03-31-2020	10-Q
19	03-19-2020	12-31-2019	10-K
20	11-25-2019	09-30-2019	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Phathom Pharmaceuticals Prices Offering Of...
08/19/2024 12:02:50

Needham Reiterates Buy on Phathom Pharmace...
08/19/2024 09:37:24

Needham analyst Joseph Stringer reiterates Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and maintains $26 price target.

HC Wainwright & Co. Reiterates Buy on Phat...
08/12/2024 10:00:51

HC Wainwright & Co. analyst Matthew Caufield reiterates Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and maintains $...

Needham Reiterates Buy on Phathom Pharmace...
08/12/2024 09:48:52

Needham analyst Joseph Stringer reiterates Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and maintains $26 price target.

Goldman Sachs Maintains Neutral on Phathom...
08/09/2024 15:49:48

Goldman Sachs analyst Paul Choi maintains Phathom Pharmaceuticals (NASDAQ:PHAT) with a Neutral and raises the price target f...

As Of June 30, 2024, Phathom Pharmaceutica...
08/08/2024 12:07:51

Phathom Pharmaceuticals Q2 2024 Adj. EPS $...
08/08/2024 12:06:31

CVS Caremark Adds VOQUEZNA Tablets To Nati...
07/30/2024 12:11:18

Now Accessible To Over 116M Commercially Covered Lives; First FDA-Approved PCAB For GERD Treatment In Over 30 Years, Says Phath...

Needham Reiterates Buy on Phathom Pharmace...
07/26/2024 10:22:01

Needham analyst Joseph Stringer reiterates Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and maintains $26 price target.

Needham Reiterates Buy on Phathom Pharmace...
07/22/2024 12:20:14

Needham analyst Joseph Stringer reiterates Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and maintains $26 price target.

HC Wainwright & Co. Reiterates Buy on Phat...
07/19/2024 10:41:33

HC Wainwright & Co. analyst Matthew Caufield reiterates Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and maintains $...

Needham Reiterates Buy on Phathom Pharmace...
07/19/2024 09:48:13

Needham analyst Joseph Stringer reiterates Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and maintains $26 price target.

The FDA Approved Phathom Pharmaceuticals' ...
07/18/2024 12:10:42

Needham Reiterates Buy on Phathom Pharmace...
07/12/2024 12:56:57

Needham analyst Joseph Stringer reiterates Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and maintains $26 price target.

Needham Reiterates Buy on Phathom Pharmace...
07/08/2024 10:20:38

Needham analyst Joseph Stringer reiterates Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and maintains $26 price target.

Needham Reiterates Buy on Phathom Pharmace...
06/28/2024 15:02:23

Needham analyst Joseph Stringer reiterates Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and maintains $26 price target.

Needham Reiterates Buy on Phathom Pharmace...
06/21/2024 14:05:24

Needham analyst Joseph Stringer reiterates Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and maintains $26 price target.

Needham Reiterates Buy on Phathom Pharmace...
06/14/2024 12:44:37

Needham analyst Joseph Stringer reiterates Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and maintains $26 price target.

Needham Reiterates Buy on Phathom Pharmace...
06/07/2024 12:30:45

Needham analyst Joseph Stringer reiterates Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and maintains $26 price target.

Needham Reiterates Buy on Phathom Pharmace...
05/31/2024 12:26:19

Needham analyst Joseph Stringer reiterates Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and maintains $26 price target.